We can't find the internet
Attempting to reconnect
18838.1 PFLS-LS
Development of early lead-like small molecules targeting a bacterial transcriptional regulator to treat infections caused by the Gram-negative pathogen Acinetobacter baumannii.
Résumé
Development of early lead-like small molecules targeting a bacterial transcriptional regulator to treat infections caused by the Gram-negative pathogen Acinetobacter baumannii.
Textes supplémentaires
Abstract
Acinetobacter baumannii is a Gram-negative bacterium of the ESKAPE-pathogen group and listed as one of the top priority dangerous organisms. The majority of clinical A. baumannii isolates (63%) are multidrug resistant. This project aims at developing an early lead-like small molecule against a transcriptional regulator of Acinetobacter ssp. These molecules will represent a new class of antibiotics active against a novel target family in Gram-negative antibacterial research.
Participants
Marc Gitzinger
Wirtschaftspartner
BioVersys AG Marc Gitzinger Hochbergerstrasse 60c 4057 Basel BS CH
Richard Kammerer
Kontaktperson
richard.kammerer@psi.ch
PSI, Paul Scherrer Institut Richard Kammerer OFLC/ 106 5232 Villigen PSI AG CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2017-02-28
- Date de fin
- 2019-12-31
- Coûts totaux approuvés
- CHF 361238.00
- Section
- 60 Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%